ASSOCIATION OF RELATIVE TELOMERE LENGTH
AND RISK OF HIGH HUMAN PAPILLOMAVIRUS LOAD
IN CERVICAL EPITHELIAL CELLS
Albosale A H, Mashkina E V
*Corresponding Author: Dr. Abbas Hadi Albosale, Genetics Department, Southern Federal University,
344090, Stachki, 194/1, Rostov-on-Don Province, Russia. E-mail: abbashammadi4@gmail.com
page: 65
|
|
REFERENCE
1. Herrmann M, Pusceddu I, März W, Herrmann W.
Telomere biology and age-related diseases. Clin
Chem Lab Med. 2018; 56(8): 12101222.
2. Armstrong CA, Tomita K. Fundamental mechanisms
of telomerase action in yeasts and mammals: understanding
telomeres and telomerase in cancer cells.
Open Biol. 2017;7(3): 160338.
3. Bernal A, Tusell L. Telomeres: Implications for Cancer
Development. Int J Mol Sci. 2018; 19(1): 294.
4. Zhu X, Han W, Xue W, Zou Y, Xie C, Du J, et al. The
association between telomere length and cancer risk
in population studies. Sci Rep. 2016; 6(1): 22243.
5. Caocci G, Greco M, Delogu G, Secchi C, Martino B,
Labate C, et al. Telomere length shortening is associated
with treatment-free remission in chronic myeloid
leukemia patients. J Hematol Oncol. 2016; 9(1): 63.
6. Okamoto K, Seimiya H. Revisiting Telomere Shortening
in Cancer. Cells. 2019; 8(2): 107.
7. Srinivas N, Rachakonda S, Kumar R. Telomeres and
Telomere Length: A General Overview. Cancers (Basel).
2020; 12(3): 558.
8. Jafri MA, Ansari SA, Alqahtani MH, Shay JW. Roles
of telomeres and telomerase in cancer, and advances
in telomerase-targeted therapies. Genome Med. 2016;
8(1): 69.
9. Shay JW. Role of Telomeres and Telomerase in Aging
and Cancer. Cancer Discov. 2016; 6(6): 584593.
10. Pańczyszyn A, Boniewska-Bernacka E, Głąb G. Telomeres
and Telomerase During Human Papillomavirus-
Induced Carcinogenesis. Mol Diagn Ther. 2018;
22(4): 421430.
11. Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan
K. Prevalence and risk factors of HPV
infection among women from various provinces
of the world. Arch Gynecol Obstet. 2012; 285(3):
771777.
12. Guan P, Howell‐Jones R, Li N, Bruni L, de Sanjosé
S, Franceschi S, et al. Human papillomavirus types
in 115,789 HPV‐positive women: a meta‐analysis
from cervical infection to cancer. Int J cancer. 2012;
131(10): 23492359.
13. Wang X, Huang X, Zhang Y. Involvement of Human
Papillomaviruses in Cervical Cancer. Front Microbiol.
2018; 9: 2896.
14. Park Y, Kim T-J, Hwang C-S, Cho CH, Jeong DH,
Seong SJ, et al. Risk of cervical dysplasia among
human papillomavirus-infected women in Korea:
a multicenter prospective study. J Gynecol Oncol.
2019; 30(3). doi:10.3802/jgo.2019.30.e50.
15. Suligoi B, Vittori G, Salfa MC, Timelli L, Corsini D,
Fattorini G, et al. Prevalence and incidence of external
genital warts in a sample of Italian general female
population. BMC Infect Dis. 2017; 17(1): 126.
16. Anorlu RI. What is the significance of the HPV epidemic?
Can J Urol. 2008; 15(1): 38603865.
17. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre
LA, Jemal A. Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide
for 36 cancers in 185 countries. CA Cancer J Clin.
2018; 68(6): 394424.
18. Kombe AJK, Li B, Zahid A, Mengist HM, Bounda
G-A, Zhou Y, et al. Epidemiology and Burden of Human
Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public
Heal. 2020; 8.
19. Zhang Y, Dakic A, Chen R, Dai Y, Schlegel R, Liu X.
Direct HPV E6/Myc interactions induce histone modifications,
Pol II phosphorylation, and hTERT promoter
activation. Oncotarget. 2017; 8(56): 9632396339.
20. Molano M, Mart�n D, Moreno‑Acosta P,
Hern�ndez G, Cornall A, Buitrago O, et al. Telomerase
activity in cervical scrapes of women with
high‑grade cervical disease: A nested case-control
study. Oncol Lett. 2017; 15(1): 354360.
21. Ustaoglu M, Bektas A, Bedir A, Bakir T, Duzgun A,
Nar R, et al. The telomere length of gastric mucosal
samples and peripheral blood lymphocytes in patients
who have undergone Billroth II distal gastrectomy.
Arch Med Sci. 2020; 16(3): 577583.
22. Federal Budget Institute of Science Central Research
Institute for Epidemiology. Guidelines to AmpliSens
HPV HCR screen-titre-FRT PCR kit. Available at:
https://interlabservice.ru/upload/iblock/a5b/Guidelines%
20to%20AmpliSens%C2%AE%20HPV%20
HCR%20screen-titre-FRT%20PCR%20kit%20(update%
2028.07.2021).pdf.2018.
23. Federal Budget Institute of Science Central Research
Institute for Epidemiology. AmpliSens
HPV HCR genotype-titre-FRT PCR kit Instruction
Manual. available at: http://www.theranostica.co.il/
wp-content/uploads/2015/12/HPV-HCR-genotype-
FRT-211212.pdf. 2018.
24. Cawthon RM. Telomere measurement by quantitative
PCR. Nucleic Acids Res. 2002; 30(10): 47e 47.
25. Rao X, Huang X, Zhou Z, Lin X. An improvement
of the 2ˆ (delta delta CT) method for quantitative
real-time polymerase chain reaction data analysis.
Biostat Bioinforma Biomath. 2013; 3(3): 71.
26. Wang L, Wang P, Ren Y, Du J, Jiang J, Jia X, et
al. Prevalence of High-Risk Human Papillomavirus
(HR-HPV) Genotypes and Multiple Infections in Cervical
Abnormalities from Northern Xinjiang, China.
PLoS One. 2016; 11(8):e0160698.
27. Luo H, Belinson JL, Du H, Liu Z, Zhang L, Wang
C, et al. Evaluation of Viral Load as a Triage Strategy
With Primary High-Risk Human Papillomavirus
Cervical Cancer Screening. J Low Genit Tract Dis.
2017; 21(1): 1216.
28. Boscolo-Rizzo P, Rampazzo E, Polesel J, Giunco S,
Menegaldo A, Mantovani M, et al. Predictive and
prognostic significance of telomerase levels/telomere
length in tissues and peripheral blood in head and neck
squamous cell carcinoma. Sci Rep. 2019; 9(1): 17572.
29. Plug-DeMaggio AW, Sundsvold T, Wurscher MA,
Koop JI, Klingelhutz AJ, McDougall JK. Telomere
erosion and chromosomal instability in cells expressing
the HPV oncogene 16E6. Oncogene. 2004;
23(20): 35613571.
30. Zhang A, Wang J, Zheng B, Fang X, Ångström T, Liu
C, et al. Telomere attrition predominantly occurs in
precursor lesions during in vivo carcinogenic process
of the uterine cervix. Oncogene. 2004; 23(44):
74417447.
31. Rudolph KL, Millard M, Bosenberg MW, DePinho
RA. Telomere dysfunction and evolution of intestinal
carcinoma in mice and humans. Nat Genet. 2001;
28(2): 155159.
32. OHagan RC, Chang S, Maser RS, Mohan R, Artandi
SE, Chin L, et al. Telomere dysfunction provokes regional
amplification and deletion in cancer genomes.
Cancer Cell. 2002; 2(2): 149155.
33. Dong L, Wang MZ, Zhao X, Feng R, Hu S, Zhang
Q, et al. Human papillomavirus viral load as a useful
triage tool for non-16/18 high-risk human papillomavirus
positive women: A prospective screening cohort
study. Gynecol Oncol. 2018; 148(1): 103110.
34. Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE,
Ferenczy A, Villa LL, et al. Viral load as a predictor
of the risk of cervical intraepithelial neoplasia. Int J
Cancer. 2003; 103(4): 519524.
35. Zhang D, Chen J, Hong C, Yi D, Wang F, Cui W.
High-risk human papillomavirus infection associated
with telomere elongation in patients with esophageal
squamous cell carcinoma with poor prognosis. Cancer.
2014; 120(17): 26732683.
36. Castro-Duque AF, Loango-Chamorro N, Ruiz-Hoyos
BM, Landázuri P. Telomerase activity associated with
progression of cervical lesions in a group of Colombian
patients. Rev Bras Ginecol e Obs. 2015; 37(12):
559564.
37. Pańczyszyn A, Boniewska-Bernacka E, Głąb G. Telomere
length in leukocytes and cervical smears of
women with high-risk human papillomavirus (HR
HPV) infection. Taiwan J Obstet Gynecol. 2020;
59(1): 5155.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
